Cytokine-Induced Depression: Current Status and Novel Targets for Depression Therapy

E-ISSN： 1996-3181|13|6|1066-1074

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.6, 2014-08, pp. : 1066-1074

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs

By Malemud Charles J Miller Andrew H

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 171-183

Informa Healthcare

Access to resources Recommend Favorite

Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1819-1835

Bentham Science Publishers

Access to resources Recommend Favorite

Neurobiology of Depression and Novel Antidepressant Drug Targets

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5791-5801

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A. Heilig M. Rupniak N.M.J. Steckler T. Griebel G.

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

By Paschos Konstantinos A.

CNS Drugs, Vol. 23, Iss. 9, 2009-09 ,pp. : 755-772

Adis International

Access to resources Recommend Favorite